CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,388 | $488.70 | $1.2M | 331,555 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,162 | $489.52 | $1.1M | 329,393 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,440 | $490.48 | $706K | 327,953 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −824 | $491.65 | $405K | 327,129 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $492.54 | $236K | 326,649 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $493.72 | $79K | 326,489 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −155 | $495.17 | $77K | 326,334 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −525 | $496.38 | $261K | 325,809 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −766 | $497.27 | $381K | 325,043 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −270 | $498.38 | $135K | 324,773 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −90 | $498.90 | $45K | 324,683 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $500.05 | $120K | 324,443 |
| 2026-09-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 375,910 | ||
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $489.61 | $118K | 333,703 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −424 | $490.54 | $208K | 333,279 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −736 | $491.45 | $362K | 332,543 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −628 | $492.67 | $309K | 331,915 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,645 | $493.70 | $812K | 330,270 |
| 2026-09-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,337 | $494.66 | $661K | 328,933 |
Page 33 of 121 · 2,404 trades